Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Wells

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
DICP : the Annals of Pharmacotherapy|September 1, 1990
Verapamil in the treatment of schizophreniaB G Wells
Pharmacotherapy|November 11, 1999
Underrecognition and undertreatment of depression: what is the pharmacist's culpability?B G Wells
The Annals of Pharmacotherapy|July 1, 1994
Amiloride in lithium-induced polyuriaB G Wells
Pharmacotherapy|February 24, 2001
A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Board of Pharmaceutical SpecialtiesB G Wells, R J Bertin
Neuropsychologia|January 1, 1990
EEG alpha asymmetries in stutterers and non-stutterers: effects of linguistic variables on hemispheric processing and fluencyB G Wells, W H Moore
Pediatrics|April 1, 1992
Fluoxetine/norfluoxetine concentrations in human milkK J Burch, B G Wells
Pharmacotherapy|September 1, 1981
Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochlorideB G Wells, A J Gelenberg
DICP : the Annals of Pharmacotherapy|July 1, 1989
Bromocriptine in treatment of depressionB G Wells, P A Marken
The Annals of Pharmacotherapy|February 1, 1993
Are calcium-channel blockers effective in the treatment of tardive dyskinesia?M Cates, K Lusk, B G Wells
Cardiovascular Research|April 1, 1971
Thermodilution measurement of left and right ventricular outputsE D Silove, T Cantez, B G Wells
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
DICP : the Annals of Pharmacotherapy|September 1, 1990
Verapamil in the treatment of schizophreniaB G Wells
Pharmacotherapy|November 11, 1999
Underrecognition and undertreatment of depression: what is the pharmacist's culpability?B G Wells
The Annals of Pharmacotherapy|July 1, 1994
Amiloride in lithium-induced polyuriaB G Wells
Pharmacotherapy|February 24, 2001
A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Board of Pharmaceutical SpecialtiesB G Wells, R J Bertin
Neuropsychologia|January 1, 1990
EEG alpha asymmetries in stutterers and non-stutterers: effects of linguistic variables on hemispheric processing and fluencyB G Wells, W H Moore
Pediatrics|April 1, 1992
Fluoxetine/norfluoxetine concentrations in human milkK J Burch, B G Wells
Pharmacotherapy|September 1, 1981
Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochlorideB G Wells, A J Gelenberg
DICP : the Annals of Pharmacotherapy|July 1, 1989
Bromocriptine in treatment of depressionB G Wells, P A Marken
The Annals of Pharmacotherapy|February 1, 1993
Are calcium-channel blockers effective in the treatment of tardive dyskinesia?M Cates, K Lusk, B G Wells
Cardiovascular Research|April 1, 1971
Thermodilution measurement of left and right ventricular outputsE D Silove, T Cantez, B G Wells
Pageof 4